1 not yet recruiting, 1 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Not yet recruiting 1, Unknown 1 |
Follow shexiang baoxin: new trials by email Literature Review of shexiang baoxin trials Research Report on shexiang baoxin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction Aspirin, Shexiang Baoxin Pill - Acute Myocardial Infarction (AMI), Percutaneous Coronary Intervention (PCI) | Phase 4 | Not yet recruiting | Shanghai Hutchison Pharmaceuticals Limited | 9588 | 2025-09-01 | 2025-09-04 |
| Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to Revascularization Shexiang Baoxin pill, SBP placebo, Aspirin Enteric-coated Tablets - Coronary Artery Disease(CAD) | Phase 4 | Unknown | Jun Li | 440 | 2017-06-01 | 2017-04-04 |
Jun Li (1) · Shanghai Hutchison Pharmaceuticals Limited (1)
China (1)
Jie Wang, MD (1)
PMID 20432394, PMID 20531008, PMID 20681275, PMID 22019563, PMID 23303884, PMID 27480425, PMID 27847338, PMID 29444778